ShanghaiTech University Knowledge Management System
PAQR3 modulates blood cholesterol level by facilitating interaction between LDLR and PCSK9 | |
2019-05 | |
发表期刊 | METABOLISM-CLINICAL AND EXPERIMENTAL (IF:10.8[JCR-2023],10.6[5-Year]) |
ISSN | 0026-0495 |
卷号 | 94页码:88-95 |
发表状态 | 已发表 |
DOI | 10.1016/j.metabol.2019.02.005 |
摘要 | Objective: Low-density lipoprotein cholesterol (LDL-C) is the hallmark of atherosclerotic cardiovascular diseases. The hepatic LDL receptor (LDLR) plays an important role in clearance of circulating LDL-C. PCSK9 facilitates degradation of LDLR in the lysosome and antagonizing PCSK9 has been successfully used in the clinic to reduce blood LDL-C level. Here we identify a new player that modulates LDLR interaction with PCSK9, thus controlling LDLR degradation and cholesterol homeostasis. |
关键词 | Low-density lipoprotein cholesterol LDLR PCSK9 Endosome Protein degradation |
收录类别 | SCI ; SCIE |
语种 | 英语 |
资助项目 | Chinese Academy of Sciences[XDA12010102] ; Chinese Academy of Sciences[QYZDJ-SSW-SMC008] ; Chinese Academy of Sciences[ZDRW-ZS-2016-8] ; Chinese Academy of Sciences[Y817X11141] |
WOS研究方向 | Endocrinology & Metabolism |
WOS类目 | Endocrinology & Metabolism |
WOS记录号 | WOS:000470306600010 |
出版者 | W B SAUNDERS CO-ELSEVIER INC |
WOS关键词 | LOW-DENSITY-LIPOPROTEIN ; SUBTILISIN/KEXIN TYPE 9 ; HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA ; MONOCLONAL-ANTIBODY ; SERINE-PROTEASE ; PROPROTEIN ; RECEPTOR ; EFFICACY ; SAFETY ; TOLERABILITY |
原始文献类型 | Article |
引用统计 | 正在获取...
|
文献类型 | 期刊论文 |
条目标识符 | https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/48973 |
专题 | 生命科学与技术学院_博士生 生命科学与技术学院_特聘教授组_陈雁组 |
通讯作者 | Chen, Yan |
作者单位 | 1.Univ Chinese Acad Sci, Chinese Acad Sci, CAS Key Lab Nutr Metab & Food Safety, Shanghai Inst Nutr & Hlth,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China 2.Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China |
通讯作者单位 | 生命科学与技术学院 |
推荐引用方式 GB/T 7714 | Huang, Meiqin,Zhao, Zilong,Cao, Qianqian,et al. PAQR3 modulates blood cholesterol level by facilitating interaction between LDLR and PCSK9[J]. METABOLISM-CLINICAL AND EXPERIMENTAL,2019,94:88-95. |
APA | Huang, Meiqin.,Zhao, Zilong.,Cao, Qianqian.,You, Xue.,Wei, Siying.,...&Chen, Yan.(2019).PAQR3 modulates blood cholesterol level by facilitating interaction between LDLR and PCSK9.METABOLISM-CLINICAL AND EXPERIMENTAL,94,88-95. |
MLA | Huang, Meiqin,et al."PAQR3 modulates blood cholesterol level by facilitating interaction between LDLR and PCSK9".METABOLISM-CLINICAL AND EXPERIMENTAL 94(2019):88-95. |
条目包含的文件 | ||||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 |
修改评论
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。